6051 - 6060 of 9145 Results
Title
Year
- Long-lasting effects of transcranial static magnetic field stimulation on motor cortex excitability2018OPENTitle: Long-lasting effects of transcranial static magnetic field stimulation on motor cortex excitabilityJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 676End Page: 688Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.02.005Best OA location URL: https://doaj.org/article/286cb69d15674e6486d6649e6ac98ed4Citation Count: 77
- Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms2020OPENTitle: Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying MechanismsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 64End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28345Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28345Citation Count: 75
- Deep clinical and neuropathological phenotyping of Pick disease2015RESTRICTEDTitle: Deep clinical and neuropathological phenotyping of Pick diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 2Start Page: 272End Page: 287Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24559Citation Count: 208
-
OPENTitle: Protein network analysis links the NSL complex to Parkinson’s disease via mitochondrial and nuclear biologyJournal Name: Molecular OmicsPublisher: Oxford University Press (OUP)Vol: 19Issue #: 8Start Page: 668End Page: 679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d2mo00325bBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2023/mo/d2mo00325bCitation Count: 0
-
OPENTitle: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning studyJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 1Issue #: 5Start Page: e222End Page: e231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0Best OA location URL: http://www.thelancet.com/article/S2589750019301050/pdfCitation Count: 119
-
OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 17
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial2011RESTRICTEDTitle: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 309End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4Citation Count: 674
- A novel homozygous SQSTM1 frameshift variant in a Filipino adolescent with childhood-onset ataxia and gaze palsy2026RESTRICTEDTitle: A novel homozygous SQSTM1 frameshift variant in a Filipino adolescent with childhood-onset ataxia and gaze palsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol:Issue #:Start Page: 108233End Page: 108233Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108233Citation Count: 1
-
OPENTitle: A validation study of the Clinician's Tardive Inventory (CTI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107812End Page: 107812Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107812Citation Count: 0
-
OPENTitle: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptorsJournal Name: Molecular Neurodegeneration AdvancesPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s44477-025-00016-7Best OA location URL: https://doi.org/10.1186/s44477-025-00016-7Citation Count: 0